Bio-Techne
TECH
#2075
Rank
S$11.79 B
Marketcap
S$75.69
Share price
0.31%
Change (1 day)
-25.96%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): S$0.67

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is S$0.64. In 2024 the company made an earnings per share (EPS) of S$1.29 a decrease over its 2023 EPS that were of S$1.83.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$0.67-48.06%
2024S$1.29-29.58%
2023S$1.83-14.97%
2022S$2.1524.16%
2021S$1.7317.98%
2020S$1.47-10.94%
2019S$1.65101.57%
2018S$0.82-16.99%
2017S$0.9945.02%
2016S$0.68-20.97%
2015S$0.86-14.97%
2014S$1.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
S$22.36 3,368.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
S-$31.35-4,962.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
S$7.18 1,014.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
S$6.29 876.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
S$2.41 273.74%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
S$9.75 1,412.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
S-$0.27-142.00%๐Ÿ‡บ๐Ÿ‡ธ USA